Novartis’s tislelizumab phase-III trial data shows survival results in esophageal cancer

Read more

Sanofi launches health brand with non-profit treatments for low-income countries

Read more

Antibody therapy less effective against new Omicron strains: Lancet

Read more

Aurigene inks drug discovery, development pact with US-based EQRx

Read more

Sigachi Industries ventures into human nutritional segment

Read more

Namitesh Roy Choudhury assumes role of Vice Chairman and Managing Director for LANXESS India region

Read more

NITI Aayog releases compendium of AYUSH practices to manage COVID-19

Read more

Novavax expects COVID vaccine targetting Omicron in fourth quarter

Read more

Oxford Biomedica signs new deal to make AstraZeneca COVID shot

Read more

Serum Institute seeks nod to export 32.4 lakh doses of its COVID vaccine Covovax to US

Read more